Article

Antigenic phenotype of cultured human osteoblast-like cells.

Department of Stomatology, Immunology Section, Institute of Neuroscience, University of Granada, Madrid, Spain.
Cellular Physiology and Biochemistry (Impact Factor: 3.55). 02/2002; 12(5-6):359-64. DOI: 10.1159/000067906
Source: PubMed

ABSTRACT Osteoblasts are classically considered to play an important role during bone tissue development, and to be involved in the formation of mineralized bone matrix. Recent reports have suggested that they can also exert some activities directly associated with the immune system (cytokine synthesis and antigen presentation). Moreover, some authors have found antigens on osteoblast-like cells normally expressed by other cells with a common origin in bone marrow.
We isolated and cultured human osteoblast-like lines and studied their antigenic phenotype with flow cytometry using monoclonal antibodies against antigens associated with hematopoietic cells.
Cultured cells expressed CD34, but were negative for CD45. B cell antigens CD20 and CD23 and myelomonocytic antigens CD11b, CD13, and CD16 were detected. Expression of CD3, CD14, CD15 and CD68 was negative, whereas CD25 expression was positive. CD56, an antigen expressed on NK cells, was positive. These cells were CD10, CD44, CD54, CD80, CD86 and HLA-DR positive, as previously described. An antigen specific to follicular dendritic cells was also observed on cultured osteoblast-like cells.
The antigenic phenotypes of human osteoblast-like cells and FDC are similar. These data suggest that osteoblasts may be functionally related to certain dendritic cells and may play an additional role in bone tissue to that classically assigned.

0 Followers
 · 
257 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Non-steroidal anti-inflammatory drugs (NSAIDs) can act by modulating the behavior of osteoblasts, including their proliferation, differentiation, adhesion, and migration, but not all NSAIDs have these effects. Our objective was to update the information on this issue in a review of the literature in order to offer guidance on the prescription of the appropriate NSAID(s) to patients requiring bone tissue repair.
    Life Sciences 01/2015; 123. DOI:10.1016/j.lfs.2015.01.009 · 2.30 Impact Factor
  • Journal of Materials Science Materials in Medicine 03/2015; 26(3):5451. DOI:10.1007/s10856-015-5451-1 · 2.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dioscin, a typical steroid saponin, is isolated from Dioscorea nipponica Makino and Dioscorea zingiberensis Wright. It has estrogenic activity and many studies have also reported that dioscorea plants have an effect in preventing and treating osteoporosis. However, the molecular mechanisms underlying their effect on osteoporosis treatment are poorly understood. Therefore, the present study aims to investigate the mechanism (s) by which dioscin promotes osteoblastic proliferation and differentiation in mouse pre-osteoblast like MC3T3-E1 cells and human osteoblast-like MG-63 cells. We found that dioscin (0.25 mug/ml, 0.5 mug/ml, and 1.0 mug/ml) promoted MC3T3-E1 cells and MG-63 cells proliferation and differentiation dose dependently. Western blot analysis results showed that estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta), beta-catenin and Bcl-2 protein expression increased after MC3T3-E1 cells were treated with dioscin. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that dioscin could increase the ratio of osteoprotegerin (OPG)/ receptor activator of NF-kappaB ligand (RANKL) and up-regulate the level of Lrp5 and beta-catenin. And by RNA interference analysis, we proved that the effect of dioscin increasing the ratio of OPG/ RANKL was dependent on Lrp5 pathway. In addition, we also found that these effects of dioscin were abolished by ICI 182, 780 (100 nM), an antagonist of ER, indicating that an ER signaling pathway was also involved. We also found that dioscin (0.25 mug/ml, 0.5 mug/ml, and 1.0 mug/ml) induced MG-63 cells proliferation and differentiation in a dose-dependent manner. Western blot analysis results indicated that ER-alpha, ER-beta and beta-catenin protein expression increased after MG-63 cells were treated with dioscin. The current study is the first to reveal that dioscin can promote osteoblasts proliferation and differentiation via Lrp5 and ER pathway.
    Journal of Biomedical Science 04/2014; 21(1):30. DOI:10.1186/1423-0127-21-30 · 2.74 Impact Factor

Preview

Download
4 Downloads
Available from